| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Research and development | $2.6M-18.9% | $3.2M+154.9% | $1.3M-35.0% | $2.0M |
| General and administrative | $5.2M+2.5% | $5.1M-10.1% | $5.6M-36.9% | $8.9M |
| Total Operating Expenses | $7.8M-5.9% | $8.3M+20.3% | $6.9M-36.6% | $10.9M |
| Loss From Operations | -$7.8M+5.9% | -$8.3M-20.3% | -$6.9M+36.6% | -$10.9M |
| Interest income | $150K-16.3% | $179K+156.0% | $70K+10.2% | $63K |
| Inducement expense | -$4.5M | — | — | — |
| Loss on equity method investment | -$492K+10.9% | -$552K-184.8% | -$194K | — |
| Other income (expense) | $165K+319.7% | -$75K-838.5% | $10K | — |
| Total other Income (Expense) | -$178K+96.4% | -$4.9M-4211.8% | -$114K-279.9% | $63K |
| Net Loss | -$8.0M+39.6% | -$13.2M-157.6% | -$5.1M+59.8% | -$12.7M |
| Loss per share, basic (in Dollars per share) | -$11.93+82.5% | -$68.01-1789.2% | -$3.60+71.7% | -$12.71 |
| Loss per share, diluted (in Dollars per share) | -$11.93+82.5% | -$68.01-1789.2% | -$3.60 | — |
| Weighted average shares, basic (in Shares) | 669K-86.2% | 4.9M+240.5% | 1.4M+42.3% | 1.0M |
| Weighted average shares, diluted (in Shares) | 669K+244.5% | 194K-86.4% | 1.4M | — |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.